Jessica Hauser Chatterjee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jessica Hauser Chatterjee has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Dennis W. Shaw
Department of Radiology University of Washington Seattle Washington USA
2 shared publicationsHeidi K. Blume
Division of Pediatric Neurology, Department of Neurology, Seattle Children's Research Institute, Norcliffe Foundation Center for Integrative Brain Research University of Washington School of Medicine Seattle Washington USA
2 shared publications- Christina L. Szperka
Children's Hospital of Philadelphia, University of Pennsylvania
1 shared publication Dwight Barry
Clinical Analytics, Seattle Children's Hospital, Seattle, Washington
1 shared publication- Elisabeth Nylander
Seattle Children's Hospital
1 shared publication Emily A. Hartford
Department of Pediatric Emergency Medicine, University of Washington, Seattle Children's Hospital, Seattle, Washington
1 shared publication
Latest Publications
- 18 September 2026
- Published by Elsevier in Pediatric Neurology
- Vol. 185, 138-148
Peripheral Nerve Blocks in the Treatment of Pediatric Headache and Neuralgia: A Scoping Review
- 18 September 2026
- Published by Elsevier in Pediatric Neurology
- Vol. 185, 138-148
Peripheral Nerve Blocks in the Treatment of Pediatric Headache and Neuralgia: A Scoping Review
- 25 March 2025
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 65 (6) , 1044-1048
Indomethacin‐responsive refractory headache: Two case reports in children after hemispherectomy for Rasmussen's encephalitis
Background: Indomethacin‐responsive headaches occur in youth and include primary headache syndromes such as hemicrania continua and paroxysmal hemicrania. Both are trigeminal autonomic cephalalgias (TACs). In pediatrics TACs are rare. Moreover, they may differ in their phenotypes and response to indomethacin compared to adults. Secondary causes for side‐locked headaches can have vascular, neoplastic, and inflammatory etiologies, emphasizing the importance of imaging in the evaluation of these headache types. Post‐craniotomy indomethacin‐responsive headaches have been described in adults, but not in children. Methods: Written consent was obtained from the patients’ families and written assent from the two children for publication. Results: We report the course of two children, both with a history of Rasmussen’s encephalitis treated with functional hemispherectomies, who subsequently developed debilitating, side‐locked, medically refractory headaches several months after surgery. Headaches were on the same side of their encephalitis and surgery. In both instances, the headaches were exquisitely and rapidly responsive to indomethacin. Headache freedom was maintained on low doses of indomethacin (0.14‐0.5 mg/kg/day). Conclusion: In cases of refractory side‐locked headaches following a craniotomy or neuroinflammatory condition in children, one may consider indomethacin as a treatment option after evaluation for other secondary etiologies.
- 25 March 2025
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 65 (6) , 1044-1048
Indomethacin‐responsive refractory headache: Two case reports in children after hemispherectomy for Rasmussen's encephalitis
Background: Indomethacin‐responsive headaches occur in youth and include primary headache syndromes such as hemicrania continua and paroxysmal hemicrania. Both are trigeminal autonomic cephalalgias (TACs). In pediatrics TACs are rare. Moreover, they may differ in their phenotypes and response to indomethacin compared to adults. Secondary causes for side‐locked headaches can have vascular, neoplastic, and inflammatory etiologies, emphasizing the importance of imaging in the evaluation of these headache types. Post‐craniotomy indomethacin‐responsive headaches have been described in adults, but not in children. Methods: Written consent was obtained from the patients’ families and written assent from the two children for publication. Results: We report the course of two children, both with a history of Rasmussen’s encephalitis treated with functional hemispherectomies, who subsequently developed debilitating, side‐locked, medically refractory headaches several months after surgery. Headaches were on the same side of their encephalitis and surgery. In both instances, the headaches were exquisitely and rapidly responsive to indomethacin. Headache freedom was maintained on low doses of indomethacin (0.14‐0.5 mg/kg/day). Conclusion: In cases of refractory side‐locked headaches following a craniotomy or neuroinflammatory condition in children, one may consider indomethacin as a treatment option after evaluation for other secondary etiologies.
- 6 April 2024
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 28 (7) , 641-649
Triptans in the Acute Migraine Management of Children and Adolescents: An Update
Purpose of Review To summarize recent findings regarding triptan use in the acute treatment of pediatric migraine. Recent Findings Prevalence of pediatric migraine is rising. The American Headache Society and American Academy of Neurology updated guidelines to provide evidence-based recommendations for the treatment of acute migraine in youth. In the setting of a dearth of new randomized controlled trials (RCTs), we review current guidelines, triptan use in the emergency department, and an era of secondary analyses. Summary Measuring the efficacy of triptans in pediatric migraine has been challenged by high placebo response rates. Secondary analyses, combining data from multiple RCTs, support that triptans are safe and effective in the treatment of migraine. Triptans are a vital tool and the only FDA-approved migraine-specific treatment available in pediatrics. There is a need for further studies and funding support in pediatric headache medicine.
- 6 April 2024
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 28 (7) , 641-649
Triptans in the Acute Migraine Management of Children and Adolescents: An Update
Purpose of Review To summarize recent findings regarding triptan use in the acute treatment of pediatric migraine. Recent Findings Prevalence of pediatric migraine is rising. The American Headache Society and American Academy of Neurology updated guidelines to provide evidence-based recommendations for the treatment of acute migraine in youth. In the setting of a dearth of new randomized controlled trials (RCTs), we review current guidelines, triptan use in the emergency department, and an era of secondary analyses. Summary Measuring the efficacy of triptans in pediatric migraine has been challenged by high placebo response rates. Secondary analyses, combining data from multiple RCTs, support that triptans are safe and effective in the treatment of migraine. Triptans are a vital tool and the only FDA-approved migraine-specific treatment available in pediatrics. There is a need for further studies and funding support in pediatric headache medicine.
- 19 May 2023
- Published by Elsevier in Pediatric Neurology
- Vol. 145, 115-118
Resolution of a Focal Pruritic Rash Following Neurosurgical Decompression in an Adolescent With Chiari I and Syringomyelia
- 19 May 2023
- Published by Elsevier in Pediatric Neurology
- Vol. 145, 115-118
Resolution of a Focal Pruritic Rash Following Neurosurgical Decompression in an Adolescent With Chiari I and Syringomyelia
- 3 February 2023
- Published by Elsevier in Pediatric Neurology
- Vol. 142, 68-75
Sumatriptan as a First-Line Treatment for Headache in the Pediatric Emergency Department
- 3 February 2023
- Published by Elsevier in Pediatric Neurology
- Vol. 142, 68-75
Sumatriptan as a First-Line Treatment for Headache in the Pediatric Emergency Department
- 5 April 2016
- Published by Wolters Kluwer Health in Neurology
- Vol. 86 (16_supplem)
MRI Correlates of Pediatric Neuromyelitis Optica Spectrum Disorder Syndromes (S12.006)
- 5 April 2016
- Published by Wolters Kluwer Health in Neurology
- Vol. 86 (16_supplem)
MRI Correlates of Pediatric Neuromyelitis Optica Spectrum Disorder Syndromes (S12.006)